<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高季刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc =20 230708114047&amp;utm_medium=rss&amp;ff=20230710143312&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;utm_source =镀铬<description>心血管高季刊：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20230710143312&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 7 月 10 日星期一 18:33:13 +0000</lastbuilddate><pubDate> Mon, 10 Jul 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>为治疗心血管疾病的临床医生提供基于价值的支付：美国心脏协会的政策声明</title><link/>https://pubmed.ncbi.nlm.nih.gov/37427456/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>临床医生付费正在从按服务付费过渡到基于价值的付费，报销与医疗保健质量和成本挂钩。这一点在很大程度上尚未得到满足。本政策声明回顾了基于价值的付费的当前状态，并提供了推荐的最佳实践未来的设计和实施。政策声明分为几个部分，详细介绍了……的不同方面。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 10 日。doi：10.1161/CIR.0000000000001143。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">临床医生付费正在从按服务付费过渡到基于价值的付费，报销与医疗保健质量和成本挂钩。本政策声明回顾了基于价值的付费的当前状态，并为未来的设计和实施提供了建议的最佳实践。政策声明分为几个部分，详细介绍了基于价值的支付的不同方面：(1) 关键项目设计特征（患者群体、质量衡量、成本衡量和风险调整），(2) 公平在设计和评估过程中的作用， (3) 支付调整，(4) 计划实施和评估。每个部分都包括为未来计划设计推荐的最佳实践。政策声明强调了成功基于价值的支付的 4 个关键主题。首先，计划应仔细权衡之间的激励措施其次，扩大基于价值的支付应成为改善公平性的工具，公平性是医疗质量的核心，应成为医疗保健质量的重点。项目设计和评估。第三，基于价值的支付应继续从服务收费转向更灵活的资助，使临床医生能够将资源集中在最能帮助患者的干预措施上。最后，成功的项目应该找到方法来引导临床医生的内在这些原则应该指导临床医生基于价值的支付模式的未来发展。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37427456/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37427456</a> | DOI： <a href=https://doi.org/10.1161/CIR.0000000000001143>10.1161/CIR.0000000000001143</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37427456</guid><pubDate> Mon, 10 Jul 2023 06:00:00 -0400</pubDate><dc:creator>亚历山大·桑杜</dc:creator><dc:creator>保罗·A·海登赖希</dc:creator><dc:creator>威廉·博登</dc:creator><dc:creator>史蒂文·农夫</dc:creator><dc:creator>P 迈克尔·何</dc:creator><dc:creator>格默里斯·哈蒙德</dc:creator><dc:creator>詹妮·C·约翰逊</dc:creator><dc:creator>Rishi K Wadhera更多</dc:creator><dc:creator>杰森·H·瓦斯菲</dc:creator><dc:creator>凯茜·比加</dc:creator><dc:creator>埃德温·高桥</dc:creator><dc:creator>Khamal D Misra更多</dc:creator><dc:creator>凯伦·E·乔恩特·马多克斯</dc:creator><dc:creator>美国心脏协会倡导协调委员会</dc:creator><dc:date>2023-07-10</dc:date><dc:source>循环</dc:source><dc:title>为治疗心血管疾病的临床医生提供基于价值的支付：美国心脏协会的政策声明</dc:title><dc:identifier>下午：37427456</dc:identifier><dc:identifier>号码：10.1161/CIR.0000000000001143</dc:identifier></item><item><title>组织细胞外囊泡的多组学鉴定了动脉粥样硬化和钙化性主动脉瓣狭窄的独特调节剂</title><link/>https://pubmed.ncbi.nlm.nih.gov/37427430/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>结论：第一个针对人类颈动脉斑块和钙化主动脉瓣的比较蛋白质组学研究确定了动脉粥样硬化与主动脉瓣狭窄的独特驱动因素，并暗示 EVs 与晚期心血管钙化有关。我们描述了一种囊泡组学策略，用于分离、纯化和研究来自动脉粥样硬化和主动脉瓣狭窄的蛋白质和 RNA 货物。 EVs 被捕获在纤维钙化组织中。通过网络方法整合囊泡蛋白质组学和转录组学揭示了组织 EVs 在……中的新作用。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 10 日。doi：10.1161/CIRCULATIONAHA.122.063402。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：不到 50% 的主动脉瓣钙化患者伴有动脉粥样硬化，这意味着不同的发病机制。虽然循环细胞外囊泡 (EV) 是心血管疾病的生物标志物，但组织截留的 EV 与早期矿化有关，但它们的负载、功能，并且对疾病的贡献仍然未知。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：对人颈动脉内膜切除标本 (n=16) 和狭窄主动脉瓣 (n=18) 进行疾病分期特异性蛋白质组学。从人颈动脉中分离组织 EV（正常，n=6；患病，n=4）通过酶消化、（超）离心和通过蛋白质组学、CD63-免疫金电子显微镜和纳米颗粒跟踪分析验证的 15 级分密度梯度，对主动脉瓣（正常，n=6；患病，n=4）进行分析。对组织 EV 进行了小 RNA 测序。TargetScan 识别了 microRNA 目标。通路网络分析了优先基因，以在原代人颈动脉平滑肌细胞和主动脉瓣间质细胞中进行验证。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：疾病进展导致颈动脉斑块和钙化主动脉瓣蛋白质组（2318 个蛋白质）显着趋同（ <i>P</i> &lt;0.0001）。每个组织还保留了差异富集蛋白质的独特子集（斑块中 381 个；瓣膜中 226 个；q&lt;0.05）两种组织中受疾病调节的蛋白质中的囊泡基因本体术语增加了 2.9 倍（ <i>P</i> &lt;0.0001）。蛋白质组学在组织消化部分中鉴定出了 22 个 EV 标记。动脉和瓣膜 EV 中疾病进展而改变的蛋白质和 microRNA 靶标网络揭示了共享的参与细胞内信号传导和细胞周期调节。囊泡组学鉴定了仅在动脉或瓣膜 EV 中因疾病而差异富集的 773 种蛋白质和 80 种 microRNA（q&lt;0.05）；多组学整合发现了与颈动脉中促钙化 Notch 和 Wnt 信号传导相关的组织特异性 EV 货物。分别敲低人颈动脉平滑肌细胞中的组织特异性 EV 货物<i>FGFR2</i> 、 <i>PPP2CA</i>和<i>ADAM17</i>以及人主动脉瓣膜间质细胞中的<i>WNT5A</i> 、 <i>APP</i>和<i>APC</i>显着调节钙化。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：第一个针对人类颈动脉斑块和钙化主动脉瓣的比较蛋白质组学研究确定了动脉粥样硬化与主动脉瓣狭窄的独特驱动因素，并暗示 EVs 与晚期心血管钙化有关。我们描述了一种囊泡组学策略，用于分离、纯化和研究来自动脉粥样硬化和主动脉瓣狭窄的蛋白质和 RNA 货物。纤维钙化组织中的 EVs。通过网络方法整合囊泡蛋白质组学和转录组学揭示了组织 EVs 在调节心血管疾病中的新作用。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37427430/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37427430</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063402>10.1161/CIRCULATIONAHA.122.063402</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37427430</guid><pubDate> Mon, 10 Jul 2023 06:00:00 -0400</pubDate><dc:creator>马克·C·布拉瑟</dc:creator><dc:creator>法布里奇奥·布弗罗</dc:creator><dc:creator>阿尔达·哈鲁</dc:creator><dc:creator>曼迪·E·特纳</dc:creator><dc:creator>弗洛里安·施洛特</dc:creator><dc:creator>东英行</dc:creator><dc:creator>洛雷娜·潘塔诺</dc:creator><dc:creator>卡桑德拉·L·克利夫特</dc:creator><dc:creator>路易斯·萨迪克</dc:creator><dc:creator>萨曼莎·阿特金斯</dc:creator><dc:creator>马克西米利安·罗杰斯</dc:creator><dc:creator>陈范</dc:creator><dc:creator>阿梅莉·弗罗曼</dc:creator><dc:creator>尤金尼娅·施瓦茨</dc:creator><dc:creator>加琳娜·K·苏霍娃</dc:creator><dc:creator>西尔维娅·蒙蒂科内</dc:creator><dc:creator>乔瓦尼·卡穆西</dc:creator><dc:creator>西蒙·罗布森</dc:creator><dc:creator>西蒙·C·博迪</dc:creator><dc:creator>约亨·D·米尔施莱格尔</dc:creator><dc:creator>萨沙·辛格</dc:creator><dc:creator>相川正则</dc:creator><dc:creator>艾琳娜·相川</dc:creator><dc:date>2023-07-10</dc:date><dc:source>循环</dc:source><dc:title>组织细胞外囊泡的多组学鉴定了动脉粥样硬化和钙化性主动脉瓣狭窄的独特调节剂</dc:title><dc:identifier>下午：37427430</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.063402</dc:identifier></item><item><title>通过单细胞 RNA 测序评估心脏非编码转录组，鉴定出 FIXER，一种保守的促纤维化长非编码 RNA</title><link/> https://pubmed.ncbi.nlm.nih.gov/37427428/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>结论：我们的结果表明，lncRNA 表达足以识别构成哺乳动物心脏的各种细胞类型。重点关注心脏成纤维细胞及其衍生物，我们鉴定了肌成纤维细胞中独特表达的 lncRNA。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 10 日。doi：10.1161/CIRCULATIONAHA.122.062601。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：心脏成纤维细胞在心脏中起着至关重要的作用，特别是在受损的心肌中，成纤维细胞分化为肌成纤维细胞，导致疤痕形成和间质纤维化。纤维化与心脏功能障碍和衰竭相关，缺乏肌成纤维细胞特异性标记物阻碍了其发展靶向治疗。在这种情况下，大多数非编码基因组被转录为长非编码 RNA (lncRNA)。许多 lncRNA 在心血管系统中具有关键功能。-比蛋白质编码基因具有特异性，支持它们作为心血管系统关键决定因素的重要性细胞身份。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项研究中，我们评估了 lncRNA 转录组在非常深入的单细胞 RNA 测序中的价值。我们分析了梗死后心脏非肌细胞中的 lncRNA 转录组，并探讨了成纤维细胞和肌成纤维细胞群体中的异质性。成为治疗心脏病的新靶点。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们证明心脏细胞身份可以通过单细胞实验中 lncRNA 的唯一表达来定义。在这项分析中，我们鉴定了相关肌成纤维细胞亚群中富集的 lncRNA。选择 1 个候选者，我们命名为<i>FIXER</i> （纤维形成<i>LOX</i>位点增强子 RNA） <i>FIXER</i>机械地与CBX4、E3 SUMO（小泛素样修饰剂）蛋白连接酶和转录因子结合，将CBX4靶向转录因子RUNX1的启动子以调节其表达，从而调节整个纤维形成基因程序<i>。FIXER</i>是保守的在人类中，支持其转化价值。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的结果表明，lncRNA 表达足以识别构成哺乳动物心脏的<i>各种</i>细胞类型。重点关注心脏成纤维细胞及其衍生物，我们鉴定了肌成纤维细胞中独特表达的 lncRNA。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37427428/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37427428</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.062601>10.1161 / CIRCULATIONAHA.122.062601</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37427428</guid><pubDate> Mon, 10 Jul 2023 06:00:00 -0400</pubDate><dc:creator>帕里莎·阿加戈扎德</dc:creator><dc:creator>伊莎贝尔·普莱桑斯</dc:creator><dc:creator>里卡多·贝尔纳斯科尼</dc:creator><dc:creator>托马斯·A·特雷贝尔</dc:creator><dc:creator>卡洛斯·普利多·奎特格拉斯</dc:creator><dc:creator>塔尼娅·维斯</dc:creator><dc:creator>莱奥诺·维格</dc:creator><dc:creator>穆罕默德·内米尔更多</dc:creator><dc:creator>亚历山大·萨尔</dc:creator><dc:creator>帕纳吉奥蒂斯·乔瓦达斯</dc:creator><dc:creator>罗里·约翰逊</dc:creator><dc:creator>阿兰查·冈萨雷斯</dc:creator><dc:creator>蒂埃里·佩德拉齐尼</dc:creator><dc:date>2023-07-10</dc:date><dc:source>循环</dc:source><dc:title>通过单细胞 RNA 测序评估心脏非编码转录组，鉴定出 FIXER，一种保守的促纤维化长非编码 RNA</dc:title><dc:identifier>下午：37427428</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.062601</dc:identifier></item><item><title>以人为本的心血管护理模式：证据审查：美国心脏协会的科学声明</title><link/>https://pubmed.ncbi.nlm.nih.gov/37427418/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>心血管疾病仍然是美国和全球死亡和残疾的主要原因。尽管技术进步提高了预期寿命和生活质量，但疾病负担仍在继续升级。因此，寿命延长与多种慢性心血管疾病相关。提供建议，而不考虑影响实际采用的多重发病率和卫生系统复杂性的普遍情况。... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 10 日。doi：10.1161/CIR.0000000000001141。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">心血管疾病仍然是美国和全球死亡和残疾的主要原因。尽管技术进步提高了预期寿命和生活质量，但疾病负担仍在继续升级。因此，寿命延长与多种慢性心血管疾病相关。提供建议，而不考虑影响实际采用的多发病率和卫生系统复杂性的普遍情况。这份科学声明的目的是描述针对选定的心血管疾病的现有以人为中心的护理服务模式的特征和报告的结果。我们进行了范围界定审查Ovid MEDLINE.、Embase.com、Web of Science、CINAHL Complete、Cochrane Central Register of Controlled Trials through Ovid 和 ClinicalTrials.gov（2010 年至 2022 年）。一系列研究设计，其明确目标是系统地评估选定的护理提供模式包括心血管疾病。模型的选择基于其声明的基于证据的指南、临床决策支持工具、系统评估过程的使用，以及在定义护理计划时纳入患者的观点。研究结果反映了方法学方法的变化，支持最佳护理提供模式的证据仍然受到方法不一致、报销差异以及卫生系统无法满足慢性复杂心血管疾病患者需求的限制。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37427418/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37427418</a> | DOI： <a href=https://doi.org/10.1161/CIR.0000000000001141>10.1161/CIR.0000000000001141</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37427418</guid><pubDate> Mon, 10 Jul 2023 06:00:00 -0400</pubDate><dc:creator>劳拉·P·罗西</dc:creator><dc:creator>——布拉迪·B·格兰杰</dc:creator><dc:creator>杰弗里·T·布鲁克尔</dc:creator><dc:creator>黛博拉·L·克拉布</dc:creator><dc:creator>露辛达·J·格雷文</dc:creator><dc:creator>金伯利·纽林</dc:creator><dc:creator>梅根·斯特鲁尔</dc:creator><dc:creator>玛雅·K·瓦迪维卢</dc:creator><dc:creator>贝妮塔·珍妮·沃尔顿-莫斯</dc:creator><dc:creator>布鲁斯·典狱长</dc:creator><dc:creator>安娜贝尔·桑托斯·沃尔格曼</dc:creator><dc:creator>梅丽莎·莱德斯顿</dc:creator><dc:creator>美国心脏协会心血管和中风护理委员会复杂心血管患者和家庭护理委员会；临床心脏病学委员会；以及护理质量和结果研究委员会</dc:creator><dc:date>2023-07-10</dc:date><dc:source>循环</dc:source><dc:title>以人为本的心血管护理模式：证据审查：美国心脏协会的科学声明</dc:title><dc:identifier>下午：37427418</dc:identifier><dc:identifier>号码：10.1161/CIR.0000000000001141</dc:identifier></item><item><title>开发用于突触核蛋白病成像的 α-突触核蛋白正电子发射断层扫描示踪剂</title><link/>https://pubmed.ncbi.nlm.nih.gov/37421950/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>突触核蛋白病的特征是 α-突触核蛋白 (α-Syn) 在大脑中聚集。突触核蛋白病的正电子发射断层扫描 (PET) 成像需要选择性结合 α-Syn 沉积物的放射性药物。PET 示踪剂 [^(18)F]-F0502B ，它显示出对 α-Syn 的高结合亲和力，但对 Aβ 或 Tau 原纤维没有高结合亲和力，并且优先结合大脑切片中的 α-Syn 聚集体。采用几个循环... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 6 月 27 日：S0092-8674(23)00644-X. doi: 10.1016/j.cell.2023.06.004. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">突触核蛋白病的特点是大脑中 α-突触核蛋白 (α-Syn) 聚集体的积累。突触核蛋白病的正电子发射断层扫描 (PET) 成像需要选择性结合 α-Syn 沉积物的放射性药物。PET 示踪剂 [ <sup>18</sup> F]-F0502B，显示对 α-Syn 具有高结合亲和力，但对 Aβ 或 Tau 原纤维没有高结合亲和力，并且优先与脑切片中的 α-Syn 聚集体结合。对来自多个体外原纤维、神经元内聚集体和神经退行性疾病脑切片进行多个循环的反筛选小鼠模型和人类受试者，[ <sup>18</sup> F]-F0502B 对小鼠和非人类灵长类 PD 模型大脑中的 α-Syn 沉积物进行成像。-Syn 原纤维-F0502B 复合物通过冷冻电镜显示，并揭示了 F0502B 在原纤维上的平行对角堆叠因此，[ <sup>18</sup> F]-F0502B 是一种有前途的先导化合物，用于对突触核蛋白病中聚集的 α-Syn 进行成像。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37421950/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37421950</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.06.004>10.1016/j.cell.2023.06.004</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37421950</guid><pubDate> Sat, 08 Jul 2023 06:00:00 -0400</pubDate><dc:creator>杰翔</dc:creator><dc:creator>陶友奇</dc:creator><dc:creator>夏一元</dc:creator><dc:creator>罗士林</dc:creator><dc:creator>赵勤越</dc:creator><dc:creator>李博伟</dc:creator><dc:creator>张小倩</dc:creator><dc:creator>孙云鹏</dc:creator><dc:creator>夏文成</dc:creator><dc:creator>张明明更多</dc:creator><dc:creator>成洙康</dc:creator><dc:creator>安恩熙</dc:creator><dc:creator>刘霞</dc:creator><dc:creator>谢方</dc:creator><dc:creator>关益辉</dc:creator><dc:creator>杨珍妮</dc:creator><dc:creator>卜立宏</dc:creator><dc:creator>吴胜熙</dc:creator><dc:creator>王晓川</dc:creator><dc:creator>曹学兵更多</dc:creator><dc:creator>刘丛</dc:creator><dc:creator>张振涛</dc:creator><dc:creator>李丹</dc:creator><dc:creator>叶克强</dc:creator><dc:date>2023-07-08</dc:date><dc:source>细胞</dc:source><dc:title>开发用于突触核蛋白病成像的 α-突触核蛋白正电子发射断层扫描示踪剂</dc:title><dc:identifier>下午：37421950</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.004</dc:identifier></item><item><title> TMEM106B 是介导不依赖 ACE2 的 SARS-CoV-2 细胞进入的受体</title><link/>https://pubmed.ncbi.nlm.nih.gov/37421949/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description> SARS-CoV-2 与广泛的组织向性相关，这一特征通常由宿主细胞上进入受体的可用性决定。在这里，我们证明 TMEM106B（一种溶酶体跨膜蛋白）可以作为 SARS-CoV-2 的替代受体进入血管紧张素转换酶 2 (ACE2) 阴性细胞。刺突取代 E484D 增加 TMEM106B 结合，从而增强 TMEM106B 介导的进入。TMEM106B 特异性单克隆抗体可阻断 SARS-CoV-2 感染，... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 7 月 3 日：S0092-8674(23)00645-1.doi: 10.1016/j.cell.2023.06.005.打印前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SARS-CoV-2 与广泛的组织向性相关，这一特征通常由宿主细胞上进入受体的可用性决定。在这里，我们证明 TMEM106B（一种溶酶体跨膜蛋白）可以作为 SARS-CoV-2 的替代受体进入血管紧张素转换酶 2 (ACE2) 阴性细胞。刺突取代 E484D 增加 TMEM106B 结合，从而增强 TMEM106B 介导的进入。TMEM106B 特异性单克隆抗体阻断 SARS-CoV-2 感染，证明 TMEM106B 在病毒进入中的作用。使用 X 射线晶体学、低温电子显微镜 (cryo-EM) 和氢氘交换质谱 (HDX-MS)，我们表明 TMEM106B 的管腔结构域 (LD) 与 SARS-CoV-的受体结合基序接合。 2 刺突。最后，我们表明 TMEM106B 促进刺突介导的合胞体形成，表明 TMEM106B 在病毒融合中的作用。总之，我们的研究结果确定了一种不依赖于 ACE2 的 SARS-CoV-2 感染机制，该机制涉及与受体硫酸乙酰肝素的协同相互作用和 TMEM106B。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37421949/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37421949</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.06.005>10.1016/j.cell.2023.06.005</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37421949</guid><pubDate> Sat, 08 Jul 2023 06:00:00 -0400</pubDate><dc:creator>吉姆·巴根</dc:creator><dc:creator>马丁·雅克敏</dc:creator><dc:creator>伦特耶人</dc:creator><dc:creator>埃尔斯·范斯特雷尔斯</dc:creator><dc:creator>瓦莱丽·派伊</dc:creator><dc:creator>安东尼·G·沃贝尔</dc:creator><dc:creator>瓦莱里娅·卡尔瓦雷西</dc:creator><dc:creator>斯蒂芬·R·马丁</dc:creator><dc:creator>克洛伊·鲁斯坦</dc:creator><dc:creator>诺拉·B·克罗宁</dc:creator><dc:creator>埃蒙·雷丁</dc:creator><dc:creator>亨德里克·扬·蒂博</dc:creator><dc:creator>托马斯·维克鲁斯</dc:creator><dc:creator>皮特·梅斯</dc:creator><dc:creator>弗雷德里克·德·斯梅特</dc:creator><dc:creator>Angie Yee更多</dc:creator><dc:creator>托伊·尼维查永</dc:creator><dc:creator>玛丽娜·罗尔</dc:creator><dc:creator>娜塔莉亚·佛朗哥-埃尔南德斯</dc:creator><dc:creator>埃尔维·莱恩</dc:creator><dc:creator>阿卢莎·安德烈·马姆查克</dc:creator><dc:creator>马克西姆·阿·杨-查蓬</dc:creator><dc:creator>——埃里克·布朗</dc:creator><dc:creator>彼得·切列帕诺夫</dc:creator><dc:creator>德克·戴勒曼斯</dc:creator><dc:date>2023-07-08</dc:date><dc:source>细胞</dc:source><dc:title>TMEM106B 是介导不依赖 ACE2 的 SARS-CoV-2 细胞进入的受体</dc:title><dc:identifier>下午：37421949</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.005</dc:identifier></item><item><title>有效膜张力：细胞动力学的远程积分器</title><link/>https://pubmed.ncbi.nlm.nih.gov/37419084/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>膜张力已被提议以机械方式耦合沿细胞边界的过程。在本期《细胞》中，De Belly 等人表明，局部突出或收缩会在几秒钟内引起全局膜张力增加，而仅涉及膜的张力扰动仍然是局部的。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 2023 年 7 月 6 日；186(14):2956-2958.doi <b>：</b> 10.1016/j.cell.2023.05.033。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">膜张力已被提议以机械方式耦合沿细胞边界的过程。在本期《细胞》中，De Belly 等人表明，局部突出或收缩会在几秒钟内引起全局膜张力增加，而仅涉及膜的张力扰动仍然是局部的。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37419084/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37419084</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.05.033>10.1016/j.cell.2023.05.033</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37419084</guid><pubDate> Fri, 07 Jul 2023 06:00:00 -0400</pubDate><dc:creator>基内雷·凯伦</dc:creator><dc:date>2023-07-07</dc:date><dc:source>细胞</dc:source><dc:title>有效膜张力：细胞动力学的远程积分器</dc:title><dc:identifier>下午：37419084</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.05.033</dc:identifier></item><item><title>科学总监：学术领导力的典范</title><link/>https://pubmed.ncbi.nlm.nih.gov/37419083/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>当前的学术领导模式对拥有高度活跃研究项目的科学家提出了独特的要求。具有专门科学主任的免费模式可以消除这种压力，并允许通过合作伙伴关系对社区进行更大的机构投资。这种模式。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 2023 年 7 月 6 日；186(14):2951-2955.doi <b>：</b> 10.1016/j.cell.2023.05.036。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">当前的学术领导模式对拥有高度活跃研究项目的科学家提出了独特的要求。具有专门科学主任的免费模式可以消除这种压力，并允许通过合作伙伴关系对社区进行更大的机构投资。这种模式。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37419083/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37419083</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.05.036>10.1016/j.cell.2023.05.036</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37419083</guid><pubDate> Fri, 07 Jul 2023 06:00:00 -0400</pubDate><dc:creator>卡罗琳·亨德利</dc:creator><dc:creator>安东尼奥·J·吉拉尔德斯</dc:creator><dc:date>2023-07-07</dc:date><dc:source>细胞</dc:source><dc:title>科学总监：学术领导力的典范</dc:title><dc:identifier>下午：37419083</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.05.036</dc:identifier></item><item><title>关注缺血性心脏病：从机制到防治</title><link/>https://pubmed.ncbi.nlm.nih.gov/37418309/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 《欧洲心脏杂志》2023 年 7 月 7 日；44(26):2351-2354.doi: 10.1093/eurheartj/ehad422。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37418309/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37418309</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad422>10.1093/eurheartj/ehad422</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37418309</guid><pubDate> Fri, 07 Jul 2023 06:00:00 -0400</pubDate><dc:creator>菲利波·克雷亚</dc:creator><dc:date>2023-07-07</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>关注缺血性心脏病：从机制到防治</dc:title><dc:identifier>下午：37418309</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad422</dc:identifier></item><item><title>冠状动脉旁路移植术后移植失败及其与患者特征和临床事件的关联：影像学随访临床试验的个体患者数据汇总分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37417248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>结论：在当代实践中，接受 CABG 的患者中移植失败仍然很常见，并且与不良心脏事件密切相关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 7 日。doi：10.1161/CIRCULATIONAHA.123.064090。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：移植物通畅是冠状动脉旁路移植术 (CABG) 获益的假定机制，介于移植物失败和 CABG 后临床事件之间。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们汇集了来自随机临床试验的个体患者数据，并进行了系统的 CABG 移植物成像，以评估移植物失败的发生率及其与临床危险因素的关联。主要结果是 CABG 后和成像前发生的心肌梗死或重复血运重建的复合结果。采用两阶段荟萃分析方法来评估移植失败与主要结局之间的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：纳入 7 项试验，包括 4413 名患者（平均年龄 64.4±9.1 岁；777 名女性 [17.6%]；3636 名男性 [82.4%]）和 13 163 个移植物（8740 个隐静脉移植物和 4423 个动脉移植物）。 1.02 年（Q1；Q3：1.00；1.03）。1487 名患者（33.7%）和 2190 名移植物（16.6%）发生移植失败。年龄（调整优势比 [aOR]，1.08 [每 10 年增量] [95 % CI，1.01-1.15]； <i>P</i> = 0.03）、女性（aOR，1.27 [95% CI，1.08-1.50]； <i>P</i> = 0.004）和吸烟（aOR，1.20 [95% CI，1.04-1.38]； <i>P</i> = 0.01）与移植失败独立相关，而他汀类药物则与保护作用相关（aOR，0.74 [95% CI，0.63-0.88]； <i>P</i> &lt;0.001）。CABG 和影像学评估之间发生的心肌梗死或重复血运重建（移植失败的患者为 8.0%，无移植失败的患者为 1.7%；aOR，3.98 [95% CI，3.54–4.47]； <i>P</i> &lt;0.001)。移植失败还与心肌梗死或重复血运重建的风险增加相关影像学检查后（7.8% 对比 2.0%；aOR，2.59 [95% CI，1.86–3.62]； <i>P</i> &lt;0.001）。与没有移植失败的患者相比，移植失败的患者（11.0% 对比 2.1%；aOR，2.79 [95% CI] ，2.01-3.89]； <i>P</i> &lt;0.001）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在当代实践中，接受 CABG 的患者中移植失败仍然很常见，并且与不良心脏事件密切相关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37417248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37417248</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064090>10.1161/CIRCULATIONAHA.123.064090</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37417248</guid><pubDate> Fri, 07 Jul 2023 06:00:00 -0400</pubDate><dc:creator>马里奥·高迪诺</dc:creator><dc:creator>西格丽德·桑德纳</dc:creator><dc:creator>凯文·安</dc:creator><dc:creator>阿纳尔多·迪马利</dc:creator><dc:creator>安东尼诺·迪弗朗哥</dc:creator><dc:creator>卡蒂亚·奥迪西奥</dc:creator><dc:creator>拉米亚·哈里克</dc:creator><dc:creator>罗伯托·佩雷斯格罗瓦斯-奥拉里亚</dc:creator><dc:creator>乔瓦尼·索莱蒂</dc:creator><dc:creator>斯蒂芬·E·弗雷姆斯</dc:creator><dc:creator>大卫·L·黑尔</dc:creator><dc:creator>亚历山大·库里克</dc:creator><dc:creator>安德烈·拉米</dc:creator><dc:creator>乔伊斯·佩珀</dc:creator><dc:creator>——马克·鲁尔</dc:creator><dc:creator>朱里恩·M·滕伯格</dc:creator><dc:creator>——劳拉·M·威廉森</dc:creator><dc:creator>赵强</dc:creator><dc:creator>丹尼尔·M·沃伊迪拉</dc:creator><dc:creator>迪帕克·巴特</dc:creator><dc:creator>约翰·H·亚历山大</dc:creator><dc:creator>比约恩·雷德福斯</dc:creator><dc:date>2023-07-07</dc:date><dc:source>循环</dc:source><dc:title>冠状动脉旁路移植术后移植失败及其与患者特征和临床事件的关联：影像学随访临床试验的个体患者数据汇总分析</dc:title><dc:identifier>下午：37417248</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064090</dc:identifier></item><item><title>确定全球健康的营养优先事项：是时候更加纯粹地关注保护性食品了</title><link/>https://pubmed.ncbi.nlm.nih.gov/37414412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 6:ehad325.doi: 10.1093/eurheartj/ehad325. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37414412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37414412</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad325>10.1093/eurheartj/ehad325</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37414412</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator>达里乌什·莫扎法里安</dc:creator><dc:date>2023-07-06</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>确定全球健康的营养优先事项：是时候更加纯粹地关注保护性食品了</dc:title><dc:identifier>下午：37414412</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad325</dc:identifier></item><item><title> 80 个国家的饮食、心血管疾病和死亡率</title><link/>https://pubmed.ncbi.nlm.nih.gov/37414411/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230710143312&amp;v=2.17.9.post6+86293ac<description>结论：在世界所有地区，含有较多水果、蔬菜、坚果、豆类、鱼类和全脂乳制品的饮食与较低的 CVD 和死亡率相关，特别是在这些食物消费量较低的收入较低的国家。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 6:ehad269.doi: 10.1093/eurheartj/ehad269. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目标：利用前瞻性城乡流行病学 (PURE) 研究的数据，制定与健康结果相关且在全球适用的健康饮食评分，并将其复制到五项独立研究中，对象为来自 80 个国家的总共 245 000 人。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：PURE 研究中对来自 21 个国家的 147 642 名普通人群进行了健康饮食评分，并在来自 70 个国家的五项大型独立研究中检验了评分与事件关联的一致性。饮食评分是根据六种食物制定的，每种食物都与显着降低的死亡风险相关[即水果、蔬菜、坚果、豆类、鱼类和乳制品（主要是全脂）；分数范围，0-6]主要结局指标是全因死亡率和主要心血管事件[心血管疾病（CVD）]。在PURE中位随访9.3年期间，与饮食评分≤1分的饮食评分相比，饮食评分≥5分的饮食评分积分与较低的死亡风险[风险比 (HR) 0.70；95% 置信区间 (CI) 0.63-0.77)]、CVD (HR 0.82；0.75-0.91)、心肌梗死 (HR 0.86；0.75-0.99) 风险相关) 和中风 (HR 0.81; 0.71-0.93). 0.72-0.87)、心肌梗死 (HR 0.85; 0.71-0.99)，以及非统计显着性较低的中风风险 (HR 0.87; 0.73-1.03)。首次心肌梗死 [比值比 (OR) 0.72; 0.65-0.80] 和中风 (OR 0.57; 0.50-0.65)。与国民生产总值较高的地区相比，较高的饮食评分与死亡或 CVD 风险显着降低相关。收入（异质性 P&lt;0.0001）。PURE 评分显示与死亡或 CVD 的关联性比其他几种常见饮食评分稍强（每次比较 P&lt;0.001）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在世界所有地区，含有较多水果、蔬菜、坚果、豆类、鱼类和全脂乳制品的饮食与较低的 CVD 和死亡率相关，特别是在这些食物消费量较低的收入较低的国家。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37414411/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37414411</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad269>10.1093/eurheartj/ehad269</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37414411</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator>安德鲁·门特</dc:creator><dc:creator>马赫希德·德赫甘</dc:creator><dc:creator>苏马西·兰加拉詹</dc:creator><dc:creator>马丁·奥唐纳</dc:creator><dc:creator>Weihong Hu</dc:creator><dc:creator> Gilles Dagenais</dc:creator><dc:creator> Andreas Wielgosz</dc:creator><dc:creator> Scott A Lear</dc:creator><dc:creator> Li Wei</dc:creator><dc:creator> Rafael Diaz</dc:creator><dc:creator> Alvaro Avezum</dc:creator><dc:creator> Patricio Lopez-Jaramillo</dc:creator><dc:creator> Fernando Lanas</dc:creator><dc:creator> Sumathi Swaminathan</dc:creator><dc:creator> Manmeet Kaur</dc:creator><dc:creator> K Vijayakumar</dc:creator><dc:creator> Viswanathan Mohan</dc:creator><dc:creator> Rajeev Gupta</dc:creator><dc:creator> Andrzej Szuba</dc:creator><dc:creator> Romaina Iqbal</dc:creator><dc:creator> Rita Yusuf</dc:creator><dc:creator> Noushin Mohammadifard</dc:creator><dc:creator> Rasha Khatib</dc:creator><dc:creator> Nafiza Mat Nasir</dc:creator><dc:creator> Kubilay Karsidag</dc:creator><dc:creator> Annika Rosengren</dc:creator><dc:creator> Afzalhussein Yusufali</dc:creator><dc:creator> Edelweiss Wentzel-Viljoen</dc:creator><dc:creator> Jephat Chifamba</dc:creator><dc:creator> Antonio Dans</dc:creator><dc:creator> Khalid F Alhabib</dc:creator><dc:creator> Karen Yeates</dc:creator><dc:creator> Koon Teo</dc:creator><dc:creator> Hertzel C Gerstein</dc:creator><dc:creator> Salim Yusuf</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> European heart journal</dc:source><dc:title> Diet, cardiovascular disease, and mortality in 80 countries</dc:title><dc:identifier> pmid:37414411</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad269</dc:identifier></item><item><title> Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity</title><link/> https://pubmed.ncbi.nlm.nih.gov/37413990/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> Chimeric antigen receptor (CAR) T cell therapy effectively treats human cancer, but the loss of the antigen recognized by the CAR poses a major obstacle. We found that in vivo vaccine boosting of CAR T cells triggers the engagement of the endogenous immune system to circumvent antigen-negative tumor escape. Vaccine-boosted CAR T promoted dendritic cell (DC) recruitment to tumors, increased tumor antigen uptake by DCs, and elicited the priming of endogenous anti-tumor T cells. This process was... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jun 28:S0092-8674(23)00642-6. doi: 10.1016/j.cell.2023.06.002. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Chimeric antigen receptor (CAR) T cell therapy effectively treats human cancer, but the loss of the antigen recognized by the CAR poses a major obstacle. We found that in vivo vaccine boosting of CAR T cells triggers the engagement of the endogenous immune system to circumvent antigen-negative tumor escape. Vaccine-boosted CAR T promoted dendritic cell (DC) recruitment to tumors, increased tumor antigen uptake by DCs, and elicited the priming of endogenous anti-tumor T cells. This process was accompanied by shifts in CAR T metabolism toward oxidative phosphorylation (OXPHOS) and was critically dependent on CAR-T-derived IFN-γ. Antigen spreading (AS) induced by vaccine-boosted CAR T enabled a proportion of complete responses even when the initial tumor was 50% CAR antigen negative, and heterogeneous tumor control was further enhanced by the genetic amplification of CAR T IFN-γ expression. Thus, CAR-T-cell-derived IFN-γ plays a critical role in promoting AS, and vaccine boosting provides a clinically translatable strategy to drive such responses against solid tumors.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37413990/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37413990</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.002>10.1016/j.cell.2023.06.002</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37413990</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Leyuan Ma</dc:creator><dc:creator> Alexander Hostetler</dc:creator><dc:creator> Duncan M Morgan</dc:creator><dc:creator> Laura Maiorino</dc:creator><dc:creator> Ina Sulkaj</dc:creator><dc:creator> Charles A Whittaker</dc:creator><dc:creator> Alexandra Neeser</dc:creator><dc:creator> Ivan Susin Pires</dc:creator><dc:creator> Parisa Yousefpour</dc:creator><dc:creator> Justin Gregory</dc:creator><dc:creator> Kashif Qureshi</dc:creator><dc:creator> Jonathan Dye</dc:creator><dc:creator> Wuhbet Abraham</dc:creator><dc:creator> Heikyung Suh</dc:creator><dc:creator> Na Li</dc:creator><dc:creator> J Christopher Love</dc:creator><dc:creator> Darrell J Irvine</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Cell</dc:source><dc:title> Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity</dc:title><dc:identifier> pmid:37413990</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.002</dc:identifier></item><item><title> Human embryo live imaging reveals nuclear DNA shedding during blastocyst expansion and biopsy</title><link/> https://pubmed.ncbi.nlm.nih.gov/37413989/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> Proper preimplantation development is essential to assemble a blastocyst capable of implantation. Live imaging has uncovered major events driving early development in mouse embryos; yet, studies in humans have been limited by restrictions on genetic manipulation and lack of imaging approaches. We have overcome this barrier by combining fluorescent dyes with live imaging to reveal the dynamics of chromosome segregation, compaction, polarization, blastocyst formation, and hatching in the human... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jun 28:S0092-8674(23)00643-8. doi: 10.1016/j.cell.2023.06.003. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Proper preimplantation development is essential to assemble a blastocyst capable of implantation. Live imaging has uncovered major events driving early development in mouse embryos; yet, studies in humans have been limited by restrictions on genetic manipulation and lack of imaging approaches. We have overcome this barrier by combining fluorescent dyes with live imaging to reveal the dynamics of chromosome segregation, compaction, polarization, blastocyst formation, and hatching in the human embryo. We also show that blastocyst expansion mechanically constrains trophectoderm cells, causing nuclear budding and DNA shedding into the cytoplasm. Furthermore, cells with lower perinuclear keratin levels are more prone to undergo DNA loss. Moreover, applying trophectoderm biopsy, a mechanical procedure performed clinically for genetic testing, increases DNA shedding. Thus, our work reveals distinct processes underlying human development compared with mouse and suggests that aneuploidies in human embryos may not only originate from chromosome segregation errors during mitosis but also from nuclear DNA shedding.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37413989/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37413989</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.003>10.1016/j.cell.2023.06.003</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37413989</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Ana Domingo-Muelas</dc:creator><dc:creator> Robin M Skory</dc:creator><dc:creator> Adam A Moverley</dc:creator><dc:creator> Goli Ardestani</dc:creator><dc:creator> Oz Pomp</dc:creator><dc:creator> Carmen Rubio</dc:creator><dc:creator> Piotr Tetlak</dc:creator><dc:creator> Blake Hernandez</dc:creator><dc:creator> Eric A Rhon-Calderon</dc:creator><dc:creator> Luis Navarro-Sánchez</dc:creator><dc:creator> Carmen M García-Pascual</dc:creator><dc:creator> Stephanie Bissiere</dc:creator><dc:creator> Marisa S Bartolomei</dc:creator><dc:creator> Denny Sakkas</dc:creator><dc:creator> Carlos Simón</dc:creator><dc:creator> Nicolas Plachta</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Cell</dc:source><dc:title> Human embryo live imaging reveals nuclear DNA shedding during blastocyst expansion and biopsy</dc:title><dc:identifier> pmid:37413989</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.003</dc:identifier></item><item><title> Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern</title><link/> https://pubmed.ncbi.nlm.nih.gov/37413988/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> The Alpha, Beta, and Gamma SARS-CoV-2 variants of concern (VOCs) co-circulated globally during 2020 and 2021, fueling waves of infections. They were displaced by Delta during a third wave worldwide in 2021, which, in turn, was displaced by Omicron in late 2021. In this study, we use phylogenetic and phylogeographic methods to reconstruct the dispersal patterns of VOCs worldwide. We find that source-sink dynamics varied substantially by VOC and identify countries that acted as global and regional... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jun 7:S0092-8674(23)00641-4. doi: 10.1016/j.cell.2023.06.001. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The Alpha, Beta, and Gamma SARS-CoV-2 variants of concern (VOCs) co-circulated globally during 2020 and 2021, fueling waves of infections. They were displaced by Delta during a third wave worldwide in 2021, which, in turn, was displaced by Omicron in late 2021. In this study, we use phylogenetic and phylogeographic methods to reconstruct the dispersal patterns of VOCs worldwide. We find that source-sink dynamics varied substantially by VOC and identify countries that acted as global and regional hubs of dissemination. We demonstrate the declining role of presumed origin countries of VOCs in their global dispersal, estimating that India contributed &lt;15% of Delta exports and South Africa &lt;1%-2% of Omicron dispersal. We estimate that >;80 countries had received introductions of Omicron within 100 days of its emergence, associated with accelerated passenger air travel and higher transmissibility. Our study highlights the rapid dispersal of highly transmissible variants, with implications for genomic surveillance along the hierarchical airline network.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37413988/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37413988</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10247138/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">PMC10247138</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.001>10.1016/j.cell.2023.06.001</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37413988</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Houriiyah Tegally</dc:creator><dc:creator> Eduan Wilkinson</dc:creator><dc:creator> Joseph LH Tsui</dc:creator><dc:creator> Monika Moir</dc:creator><dc:creator> Darren Martin</dc:creator><dc:creator> Anderson Fernandes Brito</dc:creator><dc:creator> Marta Giovanetti</dc:creator><dc:creator> Kamran Khan</dc:creator><dc:creator> Carmen Huber</dc:creator><dc:creator> Isaac I Bogoch</dc:creator><dc:creator> James Emmanuel San</dc:creator><dc:creator> Jenicca Poongavanan</dc:creator><dc:creator> Joicymara S Xavier</dc:creator><dc:creator> Darlan da S Candido</dc:creator><dc:creator> Filipe Romero</dc:creator><dc:creator> Cheryl Baxter</dc:creator><dc:creator> Oliver G Pybus</dc:creator><dc:creator> Richard J Lessells</dc:creator><dc:creator> Nuno R Faria</dc:creator><dc:creator> Moritz UG Kraemer</dc:creator><dc:creator> Tulio de Oliveira</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Cell</dc:source><dc:title> Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern</dc:title><dc:identifier> pmid:37413988</dc:identifier><dc:identifier> pmc:PMC10247138</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.001</dc:identifier></item><item><title> Functional viromic screens uncover regulatory RNA elements</title><link/> https://pubmed.ncbi.nlm.nih.gov/37413987/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> The number of sequenced viral genomes has surged recently, presenting an opportunity to understand viral diversity and uncover unknown regulatory mechanisms. Here, we conducted a screening of 30,367 viral segments from 143 species representing 96 genera and 37 families. Using a library of viral segments in 3&#39; UTR, we identified hundreds of elements impacting RNA abundance, translation, and nucleocytoplasmic distribution. To illustrate the power of this approach, we investigated K5, an element... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jun 28:S0092-8674(23)00675-X. doi: 10.1016/j.cell.2023.06.007. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The number of sequenced viral genomes has surged recently, presenting an opportunity to understand viral diversity and uncover unknown regulatory mechanisms. Here, we conducted a screening of 30,367 viral segments from 143 species representing 96 genera and 37 families. Using a library of viral segments in 3&#39; UTR, we identified hundreds of elements impacting RNA abundance, translation, and nucleocytoplasmic distribution. To illustrate the power of this approach, we investigated K5, an element conserved in kobuviruses, and found its potent ability to enhance mRNA stability and translation in various contexts, including adeno-associated viral vectors and synthetic mRNAs. Moreover, we identified a previously uncharacterized protein, ZCCHC2, as a critical host factor for K5. ZCCHC2 recruits the terminal nucleotidyl transferase TENT4 to elongate poly(A) tails with mixed sequences, delaying deadenylation. This study provides a unique resource for virus and RNA research and highlights the potential of the virosphere for biological discoveries.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37413987/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37413987</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.007>10.1016/j.cell.2023.06.007</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37413987</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Jenny J Seo</dc:creator><dc:creator> Soo-Jin Jung</dc:creator><dc:creator> Jihye Yang</dc:creator><dc:creator> Da-Eun Choi</dc:creator><dc:creator> V Narry Kim</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Cell</dc:source><dc:title> Functional viromic screens uncover regulatory RNA elements</dc:title><dc:identifier> pmid:37413987</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.007</dc:identifier></item><item><title> Correction to: Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk</title><link/> https://pubmed.ncbi.nlm.nih.gov/37410859/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 Jul 7;133(2):e47. doi: 10.1161/RES.0000000000000619. Epub 2023 Jul 6.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37410859/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37410859</a> | DOI: <a href=https://doi.org/10.1161/RES.0000000000000619>10.1161/RES.0000000000000619</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37410859</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:date> 2023-07-06</dc:date><dc:source> Circulation research</dc:source><dc:title> Correction to: Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk</dc:title><dc:identifier> pmid:37410859</dc:identifier><dc:identifier> doi:10.1161/RES.0000000000000619</dc:identifier></item><item><title> Meet the First Authors</title><link/> https://pubmed.ncbi.nlm.nih.gov/37410857/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 Jul 7;133(2):106-107. doi: 10.1161/RES.0000000000000621. Epub 2023 Jul 6.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37410857/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37410857</a> | DOI: <a href=https://doi.org/10.1161/RES.0000000000000621>10.1161/RES.0000000000000621</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37410857</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:date> 2023-07-06</dc:date><dc:source> Circulation research</dc:source><dc:title> Meet the First Authors</dc:title><dc:identifier> pmid:37410857</dc:identifier><dc:identifier> doi:10.1161/RES.0000000000000621</dc:identifier></item><item><title> Vicious Twins: RyR2 Dysfunction and Structural Remodeling</title><link/> https://pubmed.ncbi.nlm.nih.gov/37410856/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 Jul 7;133(2):193-195. doi: 10.1161/CIRCRESAHA.123.323144. Epub 2023 Jul 6.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37410856/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37410856</a> | DOI: <a href=https://doi.org/10.1161/CIRCRESAHA.123.323144>10.1161/CIRCRESAHA.123.323144</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37410856</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Niels Voigt</dc:creator><dc:creator> Fitzwilliam Seibertz</dc:creator><dc:creator> Funsho E Fakuade</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Circulation research</dc:source><dc:title> Vicious Twins: RyR2 Dysfunction and Structural Remodeling</dc:title><dc:identifier> pmid:37410856</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.323144</dc:identifier></item><item><title> Extracellular Vesicle-Encapsulated AAVs for Therapeutic Gene Delivery to the Heart</title><link/> https://pubmed.ncbi.nlm.nih.gov/37409482/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Together, using 5 different in vitro and in vivo model systems, we demonstrate significantly higher potency and therapeutic efficacy of EV-AAV vectors compared with free AAVs in the presence of NAbs. These results establish the potential of EV-AAV vectors as a gene delivery tool to treat heart failure. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 6. doi: 10.1161/CIRCULATIONAHA.122.063759. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Adeno-associated virus (AAV) has emerged as one of the best tools for cardiac gene delivery due to its cardiotropism, long-term expression, and safety. However, a significant challenge to its successful clinical use is preexisting neutralizing antibodies (NAbs), which bind to free AAVs, prevent efficient gene transduction, and reduce or negate therapeutic effects. Here we describe extracellular vesicle-encapsulated AAVs (EV-AAVs), secreted naturally by AAV-producing cells, as a superior cardiac gene delivery vector that delivers more genes and offers higher NAb resistance. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We developed a 2-step density-gradient ultracentrifugation method to isolate highly purified EV-AAVs. We compared the gene delivery and therapeutic efficacy of EV-AAVs with an equal titer of free AAVs in the presence of NAbs, both in vitro and in vivo. In addition, we investigated the mechanism of EV-AAV uptake in human left ventricular and human induced pluripotent stem cell cardiomyocytes in vitro and mouse models in vivo using a combination of biochemical techniques, flow cytometry, and immunofluorescence imaging. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Using cardiotropic AAV serotypes 6 and 9 and several reporter constructs, we demonstrated that EV-AAVs deliver significantly higher quantities of genes than AAVs in the presence of NAbs, both to human left ventricular and human induced pluripotent stem cell cardiomyocytes in vitro and to mouse hearts in vivo. Intramyocardial delivery of EV-AAV9- sarcoplasmic reticulum calcium ATPase 2a to infarcted hearts in preimmunized mice significantly improved ejection fraction and fractional shortening compared with AAV9-sarcoplasmic reticulum calcium ATPase 2a delivery. These data validated NAb evasion by and therapeutic efficacy of EV-AAV9 vectors. Trafficking studies using human induced pluripotent stem cell-derived cells in vitro and mouse hearts in vivo showed significantly higher expression of EV-AAV6/9-delivered genes in cardiomyocytes compared with noncardiomyocytes, even with comparable cellular uptake. Using cellular subfraction analyses and pH-sensitive dyes, we discovered that EV-AAVs were internalized into acidic endosomal compartments of cardiomyocytes for releasing and acidifying AAVs for their nuclear uptake. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Together, using 5 different in vitro and in vivo model systems, we demonstrate significantly higher potency and therapeutic efficacy of EV-AAV vectors compared with free AAVs in the presence of NAbs. These results establish the potential of EV-AAV vectors as a gene delivery tool to treat heart failure.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37409482/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37409482</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063759>10.1161/CIRCULATIONAHA.122.063759</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37409482</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Xisheng Li</dc:creator><dc:creator> Sabrina La Salvia</dc:creator><dc:creator> Yaxuan Liang</dc:creator><dc:creator> Marta Adamiak</dc:creator><dc:creator> Erik Kohlbrenner</dc:creator><dc:creator> Dongtak Jeong</dc:creator><dc:creator> Elena Chepurko</dc:creator><dc:creator> Delaine Ceholski</dc:creator><dc:creator> Estrella Lopez-Gordo</dc:creator><dc:creator> Seonghun Yoon</dc:creator><dc:creator> Prabhu Mathiyalagan</dc:creator><dc:creator> Neha Agarwal</dc:creator><dc:creator> Divya Jha</dc:creator><dc:creator> Shweta Lodha</dc:creator><dc:creator> George Daaboul</dc:creator><dc:creator> Anh Phan</dc:creator><dc:creator> Nikhil Raisinghani</dc:creator><dc:creator> Shihong Zhang</dc:creator><dc:creator> Lior Zangi</dc:creator><dc:creator> Edgar Gonzalez Kozlova</dc:creator><dc:creator> Nicole Dubois</dc:creator><dc:creator> Navneet Dogra</dc:creator><dc:creator> Roger J Hajjar</dc:creator><dc:creator> Susmita Sahoo</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Circulation</dc:source><dc:title> Extracellular Vesicle-Encapsulated AAVs for Therapeutic Gene Delivery to the Heart</dc:title><dc:identifier> pmid:37409482</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.122.063759</dc:identifier></item><item><title> P53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload</title><link/> https://pubmed.ncbi.nlm.nih.gov/37409456/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230710143312&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: This study reveals a mechanism regulating cardiac fibroblast accumulation and ECM secretion, orchestrated in part by p53-dependent cell cycle control that governs the timing and extent of fibrosis in left ventricular pressure overload. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 Jul 6. doi: 10.1161/CIRCRESAHA.121.320324. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Cardiomyopathy is characterized by the pathological accumulation of resident cardiac fibroblasts that deposit ECM (extracellular matrix) and generate a fibrotic scar. However, the mechanisms that control the timing and extent of cardiac fibroblast proliferation and ECM production are not known, hampering the development of antifibrotic strategies to prevent heart failure. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We used the Tcf21 (transcription factor 21) <sup>MerCreMer</sup> mouse line for fibroblast-specific lineage tracing and tumor protein p53 ( <i>p53</i> ) gene deletion (called p53-cardiac fibroblasts knockout). We characterized cardiac physiology and used single-cell RNA-sequencing and in vitro studies to investigate the p53-dependent mechanisms regulating cardiac fibroblast cell cycle and fibrosis in left ventricular pressure overload induced by transaortic constriction. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Cardiac fibroblast proliferation occurs primarily between days 7 and 14 following transaortic constriction in mice, correlating with alterations in p53-dependent gene expression. P53 deletion in fibroblasts led to a striking accumulation of Tcf21-lineage cardiac fibroblasts within the normal proliferative window and precipitated a robust fibrotic response to left ventricular pressure overload. However, excessive interstitial and perivascular fibrosis does not develop in p53-cardiac fibroblasts knockout mice until after cardiac fibroblasts exit the cell cycle. Single-cell RNA sequencing revealed p53 null fibroblasts unexpectedly express lower levels of genes encoding important ECM proteins while they exhibit an inappropriately proliferative phenotype. in vitro studies establish a role for p53 in suppressing the proliferative fibroblast phenotype, which facilitates the expression and secretion of ECM proteins. Importantly, <i>Cdkn2a</i> expression and the p16 <sup>Ink4a</sup> -retinoblastoma cell cycle control pathway is induced in <i>p53</i> null cardiac fibroblasts, which may eventually contribute to cell cycle exit and fulminant scar formation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: This study reveals a mechanism regulating cardiac fibroblast accumulation and ECM secretion, orchestrated in part by p53-dependent cell cycle control that governs the timing and extent of fibrosis in left ventricular pressure overload.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37409456/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230710143312&v=2.17.9.post6+86293ac">37409456</a> | DOI: <a href=https://doi.org/10.1161/CIRCRESAHA.121.320324>10.1161/CIRCRESAHA.121.320324</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37409456</guid><pubDate> Thu, 06 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Xiaoyi Liu</dc:creator><dc:creator> Ryan M Burke</dc:creator><dc:creator> Janet K Lighthouse</dc:creator><dc:creator> Cameron D Baker</dc:creator><dc:creator> Ronald A Dirkx</dc:creator><dc:creator> Brian Kang</dc:creator><dc:creator> Yashoswini Chakraborty</dc:creator><dc:creator> Deanne M Mickelsen</dc:creator><dc:creator> Jennifer Twardowski</dc:creator><dc:creator> Stephano S Mello</dc:creator><dc:creator> John M Ashton</dc:creator><dc:creator> Eric M Small</dc:creator><dc:date> 2023-07-06</dc:date><dc:source> Circulation research</dc:source><dc:title> P53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload</dc:title><dc:identifier> pmid:37409456</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.121.320324</dc:identifier></item></channel></rss>